Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 09, 2011 18:30 ET | Source: Transition Therapeutics Inc.

Transition Therapeutics Announces the Departure of Its President and Chief Financial Officer

TORONTO, Dec. 9, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition") (TSX:TTH) (Nasdaq:TTHI) today announces that Mr. Elie Farah, the Company's President and Chief Financial Officer,...
December 01, 2011 16:01 ET | Source: Transition Therapeutics Inc.

Transition Therapeutics Announces First Quarter Fiscal 2012 Financial Results

TORONTO, Dec. 1, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI), a product-focused biopharmaceutical company developing therapeutics for...
November 29, 2011 17:11 ET | Source: Transition Therapeutics Inc.

Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2012 Financial Results on Thursday, December 1st, at 4:30 P.M. EST

TORONTO, Nov. 29, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Thursday, December 1, 2011 at 4:30 P.M....
November 22, 2011 17:32 ET | Source: Transition Therapeutics Inc.

Transition Therapeutics Completes US$5 Million Private Placement

TORONTO, Nov. 22, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI) today announced the closing of its previously disclosed private...
November 21, 2011 06:31 ET | Source: Transition Therapeutics Inc.

Transition Therapeutics Announces US$5 Million Private Placement

TORONTO, Nov. 21, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc.("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI) today announced that it has entered into agreements to issue 3,703,703...
September 27, 2011 07:01 ET | Source: Transition Therapeutics Inc.

Transition Therapeutics Announces Publication of ELND005 Phase 2 Clinical Study Data in Alzheimer's Disease

TORONTO, Sept. 27, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI) announced that Phase 2 clinical study data of ELND005 in mild to...
September 19, 2011 16:01 ET | Source: Transition Therapeutics Inc.

Transition Therapeutics Announces Fiscal 2011 Year End Financial Results

TORONTO, Sept. 19, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI), a product-focused biopharmaceutical company developing therapeutics...
September 16, 2011 17:01 ET | Source: Transition Therapeutics Inc.

Transition Therapeutics to Hold Conference Call on Full Year Fiscal 2011 Financial Results on Monday, September 19th, at 4:30 P.M. EDT

TORONTO, Sept. 16, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Monday, September 19, 2011 at 4:30 P.M....
September 09, 2011 08:01 ET | Source: Transition Therapeutics Inc.

Transition Therapeutics to Present at the Rodman and Renshaw 13th Annual Healthcare Conference

TORONTO, Sept. 9, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc.("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI) announced today that Elie Farah, President and Chief Financial Officer of...
July 15, 2011 16:15 ET | Source: Transition Therapeutics Inc.

Transition Therapeutics Announces ELND005 Phase 2 Clinical Trial Data to be Presented at the International Conference of Alzheimer's Disease (ICAD) Meeting

TORONTO, July 15, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI) announced today that data from the Phase 2 clinical trial of ELND005 in...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right